Saúde
BPHA3 — MASSA FALIDA DA BRASIL PHARMA SA
CNPJ 11.395.624/0001-71 · listed classes: BPHA3 · CVM code 22500
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -47.3%! | 1.4% | 0.3% | -10.3% | -47.1% | -75.1% | -149.5% | — | — |
| ROIC | -10.4%! | 3.7%! | 3.9%! | -2.1%! | -19.4%! | -20.7%! | -28.7%! | -348.5%! | — |
| ROA ⟶ | -9.2%! | 1.2% | 0.2% | -5.0% | -21.4% | -26.5% | -33.5% | -202.3% | 966.4%! |
| Gross margin ⟶ | 22.6% | 37.2% | 33.1% | 30.6% | 23.1% | 27.1% | 30.7% | 30.8% | 98.3%! |
| EBIT margin ⟶ | -15.9% | 2.3% | 2.8% | -1.7% | -14.9% | -15.0% | -33.2% | -290.3%! | -302.4%! |
| Net margin ⟶ | -16.7% | 0.8% | 0.1% | -4.7% | -17.3% | -19.3% | -42.2% | -313.8% | 10,996.5%! |
| Revenue growth (1y) ⟶ | — | 519.4% | 168.4% | 21.2% | 8.8% | -4.3% | -38.3% | -65.6% | -17.5%! |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 83.8% | 8.5% | -28.1% | -68.9%! |
| Net debt/EBITDA | — | -4.08x | 0.45x | 19.79x | — | — | — | — | — |
| Current ratio ⟶ | 0.72x | 2.66x | 1.81x | 1.54x | 0.74x | 0.48x | 0.21x | 0.04x | 0.06x! |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2016T3! | 348.5 | -138.1 | -39.6% | -1.1 | 1.26 | 2016-11-09 |
| 2017T1! | 129.1 | -230.9 | -178.9% | -0.9 | 9.08 | 2017-05-10 |
| 2017T2! | 191.1 | -149.9 | -78.4% | -0.7 | — | 2017-08-10 |
| 2017T3! | 134.0 | -1,075.5 | -802.8% | -0.3 | — | 2017-11-16 |
| 2018T1! | 14.7 | -151.4 | -1,031.7% | -0.1 | — | 2018-06-19 |
| 2018T2! | 2.2 | -69.5 | -3,148.8% | -0.1 | — | 2018-10-05 |
| 2018T3! | 2.3 | -12.4 | -529.7% | -0.5 | — | 2018-11-13 |
| 2019T1! | 1.6 | -23.9 | -1,454.4% | 0.1 | — | 2019-05-22 |
Full series, every quarter: GET /empresas/BPHA3/trimestres
Dividends per year
No dividends recorded. Note this can mean two different things — the company pays none, or we could not confirm. sem_mapa_na_b3
Piotroski F-Score 5/9 (2018) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2017 | DRE 3.09 | -1,621.7 | -314.3 |
| 2017 | DRE 3.07 | -1,581.2 | -313.9 |
| 2017 | DRE 3.05 | -1,500.2 | -266.2 |
| 2015 | DRE 3.01 | 3,387.5 | 2,435.9 |
| 2015 | DRE 3.02 | -2,469.1 | -1,784.7 |
| 2017 | DRE 3.01 | 516.8 | 11.6 |
| 2017 | DRE 3.02 | -357.6 | -0.4 |
| 2015 | DRE 3.07 | -701.2 | -431.8 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/BPHA3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 1,959 sessions, 2011-06-27 → 2019-06-10 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:37 UTC. If this does not match /saude, you are reading a cached copy.